Pathway to Cures is a new venture philanthropy investment fund to support efforts to tackle inherited blood disorders.  How will it work?
National Hemophilia Foundation Chief Scientific Officer Dr. Kevin Mills chats with Techstination's Fred Fishkin.

Pathway to Cures is a new venture philanthropy investment fund to support efforts to tackle inherited blood disorders. How will it work? National Hemophilia Foundation Chief Scientific Officer Dr. Kevin Mills chats with Techstination's Fred Fishkin.

Pathway to Cures is a new venture philanthropy investment fund to support efforts to tackle inherited blood disorders. &nbsp;How will it work?
National Hemophilia Foundation Chief Scientific Officer Dr. Kevin Mills chats with Techstination's Fred Fishkin.

Techstination Interview: Pathway to Cures focused on inherited blood disorders: Dr. Kevin Mills

Techstination is a daily report on consumer tech produced by tech journalist and host Fred Fishkin. Listen to full interviews and daily reports here and find more at www.techstination.com

Share Techstination Interview: Pathway to Cures focused on inherited blood disorders: Dr. Kevin Mills

Sign up to save your podcasts

Techstination Interview: Pathway to Cures focused on inherited blood disorders: Dr. Kevin Mills

Techstination Interview: Pathway to Cures focused on inherited blood disorders: Dr. Kevin Mills